Other Regulated Markets
Wherever accountability matters, the architecture holds.
The principles that make AAP defensible in pharmaceutical GMP apply directly to any market where a wrong AI output carries regulatory, safety or financial consequences.
The principles that make AAP defensible in pharmaceutical GMP apply directly to any market where a wrong AI output carries regulatory, safety or financial consequences.
| Market | Typical obligations | Where AiVACO helps |
|---|---|---|
| MedTech and diagnostics | EU MDR and IVDR, ISO 13485, ISO 14971 risk management | Technical documentation support, complaint and vigilance preparation, controlled drafting |
| Healthcare providers | Clinical risk management standards DCB0129 and DCB0160, the NHS Data Security and Protection Toolkit, UK GDPR | Grounded clinical policy and procedure knowledge, with clinical decisions kept with clinicians |
| Aerospace and defence | Export controls, AS9100 quality management, MOD JSP 936 on dependable AI | Air gapped sovereign deployment, controlled engineering knowledge, full audit trail |
| Financial services | FCA Consumer Duty, PRA SS1/23 model risk management principles | Model agnostic control, consistent outputs, evidence for model risk governance |
| Energy, utilities and critical industry | Critical national infrastructure obligations, NIS regulations, process safety | Sovereign deployment, procedure grounded assistants, deterministic verification |
